Annals of African Medicine
Home About AAM Editorial board Ahead of print Current Issue Archives Instructions Subscribe Contact us Search Login 
This article has been cited by
1Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis
Cho Naing,Maxine A. Whittaker
Infectious Diseases of Poverty.2018;7(1)
[DOI]
2Performance of a sensitive haemozoin-based malaria diagnostic test validated for vivax malaria diagnosis in Brazilian Amazon
Gisely Cardoso de Melo,Rebeca Linhares Abreu Netto,Victor Irungu Mwangi,Yanka Evellyn Alves Rodrigues Salazar,Vanderson de Souza Sampaio,Wuelton Marcelo Monteiro,Fernando Fonseca de Almeida e Val,Anne Rocheleau,Priyaleela Thota,Marcus Vinícius Guimarães Lacerda
Malaria Journal.2021;20(1)
[DOI]
3Severe vivax malaria in the Republic of Korea during the period 2000 to 2016
Seong Yeon Park,Yoon Soo Park,Yoonseon Park,Yee Gyung Kwak,Je Eun Song,Kkot Sil Lee,Shin-Hyeong Cho,Sang-Eun Lee,Hyun-Il Shin,Joon-Sup Yeom
Travel Medicine and Infectious Disease.2019;30(1)108
[DOI]
4Vivax malaria in an Amazonian child with dilated cardiomyopathy
Antonio C Martins,Jamille B Lins,Luana MN Santos,Licia N Fernandes,Rosely S Malafronte,Teresa C Maia,Melissa CV Ribera,Ricardo B Ribera,Monica da Silva-Nunes
Malaria Journal.2014;13(1)61
[DOI]
5Severe Plasmodium vivax infection in Korea
Jae Hyoung Im,Hea Yoon Kwon,JiHyeon Baek,Seong Wook Park,Areum Durey,Kyung Hee Lee,Moon-Hyun Chung,Jin-Soo Lee
Malaria Journal.2017;16(1)61
[DOI]
6Approach to Clinical Syndrome of Jaundice and Encephalopathy in Tropics
Anil C. Anand,Hitendra K. Garg
Journal of Clinical and Experimental Hepatology.2015;5(1)S116
[DOI]
7Hepatobiliary Quiz (Answers)—14 (2015)
Sahaj Rathi,Radha K. Dhiman
Journal of Clinical and Experimental Hepatology.2015;5(2)175
[DOI]
8Primaquine at alternative dosing schedules for preventing relapse in people withPlasmodium vivaxmalaria
Rachael Milligan,André Daher,Patricia M Graves
Cochrane Database of Systematic Reviews.2017;5(2)175
[DOI]
9Clinical profile of malaria at a tertiary care teaching hospital in North India
Ritu Karoli,Shobhit Shakya,Nikhil Gupta,Vineeta Mittal,AnilKumar Upadhyay
Tropical Parasitology.2021;11(1)25
[DOI]
10Altered platelet indices as potential markers of severe and complicated malaria caused by Plasmodium vivax: a cross-sectional descriptive study
Fábio A Leal-Santos,Soraya BR Silva,Natasha P Crepaldi,Andréia F Nery,Thamires OG Martin,Eduardo R Alves-Junior,Cor JF Fontes
Malaria Journal.2013;12(1)25
[DOI]
11Primaquine at alternative dosing schedules for preventing relapse in people withPlasmodium vivaxmalaria
Rachael Milligan,André Daher,Patricia M Graves
Cochrane Database of Systematic Reviews.2019;12(1)25
[DOI]
12Clinical spectrum of Plasmodium vivax infection, from benign to severe malaria: A tertiary care prospective study in adults from Delhi, India
SujataElizabeth Mathews,MohitM Bhagwati,Vinod Agnihotri
Tropical Parasitology.2019;9(2)88
[DOI]
13What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?
Carolina López,Yoelis Yepes-Pérez,Natalia Hincapié-Escobar,Diana Díaz-Arévalo,Manuel A. Patarroyo
Frontiers in Immunology.2017;8(2)88
[DOI]
14Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis
Hernando del Portillo,Fernando Val,Wuelton Marcelo Monteiro,Quique Bassat,Kim Machado,Lisiane Barbosa,Jorge Luis Salinas,André Machado Siqueira,Marcus Vinícius Guimarães Lacerda,Maria Graças Costa Alecrim
The American Journal of Tropical Medicine and Hygiene.2017;97(3)733
[DOI]
15Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis
Cho Naing,Maxine A. Whittaker,Victor Nyunt Wai,Joon Wah Mak,Hernando A. del Portillo
PLoS Neglected Tropical Diseases.2014;8(8)e3071
[DOI]
16Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax
Rachael Milligan,André Daher,Gemma Villanueva,Hanna Bergman,Patricia M Graves
Cochrane Database of Systematic Reviews.2020;8(8)e3071
[DOI]
17Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin
Tasanee Panichakul,Saranyoo Ponnikorn,Sittiruk Roytrakul,Atchara Paemanee,Suthathip Kittisenachai,Suradej Hongeng,Rachanee Udomsangpetch
Malaria Journal.2015;14(1)e3071
[DOI]
18Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: a systematic review, meta-analysis, and analysis of case reports
Manas Kotepui,Kwuntida Uthaisar Kotepui,Giovanni De Jesus Milanez,Frederick Ramirez Masangkay
BMC Infectious Diseases.2020;20(1)e3071
[DOI]
19A descriptive study of 16 severe Plasmodium vivax cases from three municipalities of Colombia between 2009 and 2013
Anthony T O’Brien,Jesica F Ramírez,Sandra P Martínez
Malaria Journal.2014;13(1)404
[DOI]
20Prevalence and Clinical Manifestations of Malaria in Aligarh, India
Umm-e Asma,Farha Taufiq,Wajihullah Khan
The Korean Journal of Parasitology.2014;52(6)621
[DOI]
21Are respiratory complications of Plasmodium vivax malaria an underestimated problem?
Fernando Val,Sara Avalos,André Alexandre Gomes,José Evelio Albornoz Zerpa,Gustavo Fontecha,André Machado Siqueira,Quique Bassat,Maria Graças Costa Alecrim,Wuelton Marcelo Monteiro,Marcus Vinícius Guimarães Lacerda
Malaria Journal.2017;16(1)621
[DOI]
  Feedback 
  Subscribe